Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Takeuchi

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
International Clinical Psychopharmacology|March 3, 2023
The importance of early and proactive use of long-acting injectable antipsychotics in the management of schizophreniaHiroyoshi Takeuchi
Nihon Hoshasen Gijutsu Gakkai Zasshi|October 19, 2010
[Adjustment of image processing parameters of REGIUS]Hiroyoshi Takeuchi
The Lancet. Psychiatry|November 4, 2023
More options, more value: a new long-acting injectable formulation of risperidoneHiroyoshi Takeuchi
The Lancet. Psychiatry|March 11, 2022
The promise and pitfalls of antipsychotic co-initiation in schizophreniaHiroyoshi Takeuchi
Schizophrenia Research|February 26, 2025
Are all antipsychotic dose reduction trials in stable schizophrenia the same?Hiroyoshi Takeuchi
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 11, 2015
[Optimal Antipsychotic Dose and Dosing Interval in the Treatment of Schizophrenia]Hiroyoshi Takeuchi
Psychiatry and Clinical Neurosciences|July 2, 2022
Priapism and Second-Generation Antipsychotics: Disproportionality Analysis of a Spontaneous Reporting System Database in JapanFuminari Misawa, Hiroyoshi Takeuchi
Journal of Psychopharmacology (Oxford, England)|May 26, 2020
Immediate versus wait-and-gradual discontinuation in antipsychotic switching: A meta-analysisHiroyoshi Takeuchi, Gary Remington
Evidence-Based Mental Health|October 14, 2015
Improving symptoms and side effects in older patients with schizophrenia with decreasing dopamine D2/3 receptor occupancy following risperidone and olanzapine dose reductionHiroyoshi Takeuchi, Gary Remington
Journal of Clinical Psychopharmacology|May 27, 2026
Therapeutic Interventions and Clinical Outcomes Following Breakthrough Psychosis on Antipsychotic Maintenance Medication (BAMM): A Retrospective Chart ReviewFuminari Misawa, Hiroyoshi Takeuchi
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
International Clinical Psychopharmacology|March 3, 2023
The importance of early and proactive use of long-acting injectable antipsychotics in the management of schizophreniaHiroyoshi Takeuchi
Nihon Hoshasen Gijutsu Gakkai Zasshi|October 19, 2010
[Adjustment of image processing parameters of REGIUS]Hiroyoshi Takeuchi
The Lancet. Psychiatry|November 4, 2023
More options, more value: a new long-acting injectable formulation of risperidoneHiroyoshi Takeuchi
The Lancet. Psychiatry|March 11, 2022
The promise and pitfalls of antipsychotic co-initiation in schizophreniaHiroyoshi Takeuchi
Schizophrenia Research|February 26, 2025
Are all antipsychotic dose reduction trials in stable schizophrenia the same?Hiroyoshi Takeuchi
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 11, 2015
[Optimal Antipsychotic Dose and Dosing Interval in the Treatment of Schizophrenia]Hiroyoshi Takeuchi
Psychiatry and Clinical Neurosciences|July 2, 2022
Priapism and Second-Generation Antipsychotics: Disproportionality Analysis of a Spontaneous Reporting System Database in JapanFuminari Misawa, Hiroyoshi Takeuchi
Journal of Psychopharmacology (Oxford, England)|May 26, 2020
Immediate versus wait-and-gradual discontinuation in antipsychotic switching: A meta-analysisHiroyoshi Takeuchi, Gary Remington
Evidence-Based Mental Health|October 14, 2015
Improving symptoms and side effects in older patients with schizophrenia with decreasing dopamine D2/3 receptor occupancy following risperidone and olanzapine dose reductionHiroyoshi Takeuchi, Gary Remington
Journal of Clinical Psychopharmacology|May 27, 2026
Therapeutic Interventions and Clinical Outcomes Following Breakthrough Psychosis on Antipsychotic Maintenance Medication (BAMM): A Retrospective Chart ReviewFuminari Misawa, Hiroyoshi Takeuchi
Pageof 21